Perimenopause and Longevity Medicine: Understanding the Transition Before Menopause

Many women begin noticing changes in their health well before they expect menopause to become relevant. Sleep becomes less predictable, menstrual cycles change, and concentration or emotional steadiness may no longer feel as reliable. Others describe increasing fatigue, difficulty maintaining muscle, or changes in abdominal fat despite relatively consistent habits.

These symptoms are frequently attributed to stress, demanding schedules, or ordinary aging. Those explanations may be partly correct, particularly during a stage of life when professional responsibilities, caregiving, and other pressures are often substantial. Yet the hormonal changes of perimenopause can also contribute, sometimes years before the final menstrual period.

At HormoneSynergy®, Dr. Kathryn Retzler has spent more than 25 years evaluating women's hormonal transitions within a broader preventive medicine framework. Perimenopause is an important period for this work because it often coincides with changes in sleep, metabolic health, cardiovascular risk factors, and body composition. Recognizing the transition can help women understand their symptoms while identifying other health concerns that deserve attention.

Perimenopause eventually progresses to menopause, defined retrospectively after 12 consecutive months without menstrual bleeding when no other cause is present. The years surrounding this transition have implications for health beyond reproduction, although the experience differs considerably among women.

For more on the changes that follow, see Menopause and Longevity Medicine.

Understanding the Hormonal Transition

Perimenopause is characterized by changes in ovarian function rather than a uniform decline in hormone levels. Ovulation becomes less predictable, menstrual cycles may shorten or lengthen, and estrogen levels can fluctuate substantially. Progesterone production also becomes more variable as ovulatory cycles become less consistent.

For most women, the transition begins during their 40s, although symptoms and menstrual changes may occur earlier. The duration varies, and no single symptom pattern describes everyone's experience.

Some women primarily notice changes in menstruation, including heavier or more frequent bleeding. Others experience hot flashes, night sweats, sleep disruption, breast tenderness, migraines, mood symptoms, or difficulty concentrating. These complaints can fluctuate with hormonal activity and may become more pronounced as menopause approaches.

Because hormone levels vary throughout the menstrual cycle and across perimenopause, an isolated laboratory result may provide limited information. For otherwise healthy women over 45 with typical symptoms and menstrual changes, clinical history is generally more useful than repeatedly measuring estrogen or follicle-stimulating hormone. Testing becomes more relevant when the presentation is atypical, menopause is suspected at a younger age, or another medical condition needs to be considered.

Thyroid dysfunction, anemia, medication effects, sleep disorders, and mood conditions may produce symptoms that overlap with perimenopause. Abnormal uterine bleeding also deserves appropriate evaluation rather than being attributed automatically to changing hormones.

Sleep, Mood, and Cognitive Function

Sleep disturbance is among the most consequential complaints during the menopausal transition. Women may have difficulty falling asleep, wake repeatedly during the night, or find themselves awake earlier than intended. Hot flashes and night sweats can contribute, although insomnia may also occur without noticeable vasomotor symptoms.

Persistent sleep disruption influences attention, memory, emotional regulation, appetite, and daytime energy. A woman who previously managed demanding responsibilities with relative ease may find herself struggling to concentrate or recover from ordinary stress. These changes can be particularly frustrating when routine medical testing offers no obvious explanation.

Fluctuating ovarian hormones may contribute to mood symptoms during perimenopause, and women with a history of depression or sensitivity to hormonal changes may be more vulnerable. Sleep loss, stressful life circumstances, and preexisting anxiety or depression can further complicate the picture.

Cognitive complaints are also common. Difficulty finding words, reduced concentration, and lapses in working memory have been described in studies of the menopausal transition. Objective changes are generally modest, and most women continue to function within normal cognitive ranges. Persistent or progressive impairment should nevertheless be evaluated rather than assumed to be hormonal.

Sleep quality is particularly important because fragmented sleep can produce cognitive symptoms independently of menopause. A clinical assessment may need to consider insomnia, obstructive sleep apnea, mood disorders, medications, and other contributors.

Related reading includes Hormones and Sleep Quality and Sleep, Mental Health, and Longevity.

Metabolic Health and Changes in Body Composition

Midlife often brings changes in body composition that are not fully reflected by body weight. Some women experience increasing abdominal fat, declining muscle mass, or reduced exercise capacity despite relatively little change on the scale.

The menopausal transition is associated with a shift toward greater central fat accumulation. Changes in estrogen signaling may contribute to this redistribution, while chronological aging, physical activity, nutrition, sleep, and genetics also influence the outcome.

Insulin sensitivity and other metabolic markers can change during midlife, although the relationship between perimenopause and insulin resistance is not uniform. Weight gain, visceral adiposity, declining activity, and existing metabolic risk may contribute independently. A woman experiencing changes in waist circumference or energy should not automatically assume that estrogen deficiency is the sole explanation.

Body composition is useful in this setting because weight alone cannot distinguish between muscle and fat. DEXA measurements can help identify changes in lean mass, total fat, and regional fat distribution, including estimates of visceral adipose tissue. These findings can inform discussions about strength training, nutrition, and metabolic risk.

Preserving skeletal muscle becomes increasingly important with age. Resistance exercise supports strength, mobility, insulin sensitivity, and physical independence, while aerobic activity contributes to cardiovascular fitness and metabolic health. Adequate dietary protein and appropriate energy intake support these efforts.

Hormone therapy is not a substitute for exercise, nutrition, or treatment of metabolic disease. Although it may influence aspects of body composition, it should not be prescribed solely for weight loss or muscle preservation.

For additional context, see Metabolic Health and Longevity Medicine, HOMA-IR and Insulin Resistance, and Body Composition and Longevity Medicine.

Cardiovascular Health During Perimenopause

Cardiovascular disease remains a major health concern for women, and the years surrounding menopause deserve attention as part of long-term prevention.

Research has associated the menopausal transition with changes in cholesterol, body fat distribution, and aspects of vascular function. Some of these changes occur independently of chronological aging, although individual risk reflects a combination of genetics, blood pressure, lipid concentrations, glucose regulation, smoking history, physical activity, and other factors.

A woman may experience relatively few menopausal symptoms while developing hypertension, worsening lipid patterns, or increasing abdominal adiposity. Conversely, substantial hot flashes or sleep disturbances do not necessarily indicate elevated cardiovascular risk. Symptom severity and vascular risk are related only imperfectly.

Preventive assessment should therefore consider established cardiovascular risk factors rather than relying on symptoms or hormone concentrations alone. Depending on the patient's history, evaluation may include a lipid profile, ApoB, lipoprotein(a), blood pressure, glucose or HbA1c, family history, and additional testing when clinically appropriate.

Advanced cardiovascular imaging may be useful in selected patients when conventional risk assessment leaves important questions unanswered. The appropriate method depends on the clinical circumstances and should not be used indiscriminately.

Menopausal hormone therapy may be appropriate for symptom management in carefully selected women, but it is not recommended as a primary strategy to prevent cardiovascular disease.

Additional information is available in Preventive Cardiology and Longevity Medicine, ApoB and Cardiovascular Risk, and Lipoprotein(a) and Longevity.

Bone Density, Muscle, and Long-Term Physical Function

Bone health becomes increasingly important as women approach menopause. Estrogen helps regulate bone remodeling, and declining estrogen levels accelerate bone loss, particularly during the late menopausal transition and early postmenopausal years.

The degree of bone loss varies. Family history, body weight, nutrition, physical activity, medications, smoking, alcohol use, and underlying medical conditions influence individual risk.

Bone density measurement with DEXA can help identify low bone mass or osteoporosis when screening is indicated. Routine screening is generally recommended for women beginning at age 65, with earlier testing appropriate for postmenopausal women who have relevant risk factors. Testing during perimenopause may also be justified by particular medical circumstances, such as a fragility fracture or a condition associated with accelerated bone loss.

Maintaining muscle strength is equally important, although bone density and muscle mass require different forms of assessment. Resistance training, weight-bearing exercise, adequate nutrition, and management of relevant medical conditions contribute to musculoskeletal health.

These measures have implications that extend well beyond body composition. Preserving strength, balance, and skeletal integrity can reduce the physical limitations associated with aging and help maintain independence later in life.

How Hormone Therapy Fits Into Perimenopause Care

Treatment during perimenopause should be guided by the woman's symptoms, medical history, reproductive circumstances, and preferences. Not every woman requires medication, and not every symptom is caused by changing ovarian hormones.

For women experiencing significant hot flashes, night sweats, or other menopausal symptoms, hormone therapy may be an appropriate option following individualized evaluation. Treatment decisions involve the patient's age, menstrual status, uterine status, cardiovascular and thrombotic risk, breast cancer history, and other contraindications.

Women who still require contraception need additional consideration because pregnancy remains possible during perimenopause. Menopausal hormone therapy is not contraception, and some women may benefit from contraceptive options that also address menstrual symptoms.

Systemic estrogen treatment generally requires adequate endometrial protection when the uterus is present. The formulation, route, dose, and accompanying progestogen should be selected according to clinical circumstances.

Testosterone is sometimes discussed in the broader context of women's hormone health, but current evidence does not support prescribing it routinely for fatigue, cognitive complaints, muscle gain, or general rejuvenation. Its principal evidence-based indication is carefully assessed hypoactive sexual desire disorder in appropriate women.

At HormoneSynergy®, hormone treatment is considered within comprehensive medical care rather than as an isolated prescription based on a laboratory value. Dr. Kathryn Retzler evaluates symptoms and treatment options in the context of the patient's broader health, with the understanding that hormone therapy can be valuable without being appropriate for every concern associated with midlife.

What a Comprehensive Perimenopause Evaluation Includes

A useful evaluation begins with a detailed medical and menstrual history. Changes in cycle timing, bleeding patterns, sleep, mood, vasomotor symptoms, sexual health, and daily functioning help establish whether perimenopause is a likely contributor to the patient's concerns.

Medical assessment should also consider conditions that can overlap with or complicate the menopausal transition. Thyroid disorders, anemia, sleep apnea, depression, medications, and metabolic disease may require specific evaluation or treatment.

At HormoneSynergy®, the Optimal Aging Assessment provides a broader preventive framework that may include advanced laboratory testing, cardiovascular risk assessment, DEXA bone density and body composition measurements, SECA body composition analysis, carotid ultrasound, and standardized cognitive testing.

Testing should answer meaningful clinical questions. A greater number of laboratory markers or imaging studies does not automatically improve care, and findings must be interpreted in the context of the individual patient.

The practical value of a comprehensive assessment is the opportunity to distinguish symptoms that may benefit from hormone treatment from conditions requiring other interventions. Improved sleep, better control of blood pressure, resistance exercise, nutritional changes, and treatment of metabolic disease may be just as important as addressing menopausal symptoms.

Perimenopause as an Opportunity for Preventive Care

Perimenopause is a normal stage of reproductive aging, but its effects on daily functioning can be substantial. Women who experience sleep disturbances, mood changes, cognitive complaints, or persistent vasomotor symptoms deserve an assessment that takes those concerns seriously.

The transition also occurs during an important period for cardiovascular and musculoskeletal prevention. Changes in blood pressure, lipids, bone density, body composition, and physical activity may develop gradually, sometimes without obvious symptoms.

Effective care begins with understanding what is changing and which findings have meaningful implications for the patient's health. Some women will benefit from hormone therapy, while others may primarily need treatment for sleep disorders, metabolic conditions, or other medical concerns. Many will benefit from addressing several factors together.

Dr. Kathryn Retzler's approach at HormoneSynergy® places these decisions within the larger goal of preserving health and physical function with age. Perimenopause offers an opportunity to reassess risks, respond to symptoms, and establish a preventive strategy suited to the decades ahead.

Related Longevity Medicine Resources

• The HormoneSynergy® Longevity Medicine Model
• Hormone Transitions and Longevity Medicine
• Menopause and Longevity Medicine
• Hormone Therapy for Women
• Preventive Cardiology and Longevity Medicine
• Body Composition and Longevity Medicine
• Longevity Medicine Resource Library

Frequently Asked Questions

At what age does perimenopause usually begin?

Perimenopause most commonly begins in a woman's 40s, although the timing varies. Changes in menstrual patterns, sleep, vasomotor symptoms, and mood may precede the final menstrual period by several years.

Can perimenopause affect metabolism and body composition?

The menopausal transition is associated with changes in fat distribution, particularly increasing abdominal adiposity. Aging, sleep, exercise, diet, and genetics also influence weight, muscle mass, and metabolic health.

Can perimenopause cause brain fog?

Some women experience changes in concentration, word retrieval, and memory during perimenopause. Hormonal fluctuations, sleep disruption, mood symptoms, and other medical conditions may contribute. Persistent or progressive cognitive impairment deserves evaluation.

Does perimenopause increase cardiovascular risk?

The menopausal transition is associated with changes in certain cardiovascular risk factors, including lipid patterns and central fat distribution. Overall cardiovascular risk depends on age, genetics, blood pressure, metabolic health, and other established factors.

Is hormone therapy necessary during perimenopause?

Not necessarily. Treatment depends on symptom severity, medical history, contraception needs, and individual preferences. Hormone therapy can be helpful for some women, while others benefit from nonhormonal treatments and targeted preventive care.

Can a blood test confirm perimenopause?

In women over 45 with typical symptoms and menstrual changes, perimenopause is usually diagnosed clinically. Because reproductive hormone levels fluctuate considerably, a single laboratory measurement may be misleading. Testing may be appropriate when symptoms are atypical or menopause is suspected at a younger age.